Operations: The company's revenue from its segment focused on the discovery, development, and commercialization of RNAi therapeutics amounts to $2.09 billion.

Estimated Discount To Fair Value: 48.8%

Alnylam Pharmaceuticals, trading at US$279.82, is significantly below its estimated fair value of US$546.39, highlighting potential undervaluation based on cash flows. Although recent earnings showed a net loss and shareholder dilution, revenue for the nine months increased to US$1.66 billion from US$1.39 billion year-on-year. With an expected annual revenue growth of 22.4% and profitability anticipated within three years, Alnylam's financial outlook appears robust despite current challenges.

• According our earnings growth report, there's an indication that Alnylam Pharmaceuticals might be ready to expand.

• Get an in-depth perspective on Alnylam Pharmaceuticals' balance sheet by reading our health report here.

Digital Realty Trust

Overview: Digital Realty Trust operates by providing a comprehensive range of data center, colocation, and interconnection solutions, with a market cap of approximately $61.53 billion.

Operations: The company's revenue primarily comes from its REIT - Commercial segment, totaling $5.37 billion.

Estimated Discount To Fair Value: 31.1%

Digital Realty Trust, trading at US$182.85, is undervalued with an estimated fair value of US$265.5, reflecting a strong cash flow position. Despite a decline in net profit margins from 16.6% to 7.5%, earnings are forecasted to grow significantly at 21% annually over the next three years, outpacing the broader US market's growth rate of 15.6%. However, interest coverage remains weak and shareholders experienced dilution recently.

• Our comprehensive growth report raises the possibility that Digital Realty Trust is poised for substantial financial growth.

• Unlock comprehensive insights into our analysis of Digital Realty Trust stock in this financial health report.

Turning Ideas Into Actions

• Access the full spectrum of 198 Undervalued US Stocks Based On Cash Flows by clicking on this link.

• Have a stake in these businesses? Integrate your holdings into Simply Wall St's portfolio for notifications and detailed stock reports.

• Invest smarter with the free Simply Wall St app providing detailed insights into every stock market around the globe.

Looking For Alternative Opportunities?

• Explore high-performing small cap companies that haven't yet garnered significant analyst attention.

• Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence.

• Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Companies discussed in this article include NasdaqCM:RKLB NasdaqGS:ALNY and NYSE:DLR.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com